CD274 and neoplasm: Based on tumor PD-L1 expression, the median (95% CI) PFS was 5.9 (4.4–not estimated) months in the < 1% subgroup and 6.7 (5.5–10.2) months in the ≥ 1% subgroup (Fig. 3B).